SACM1L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.860400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.486800E-01
Normal-vs-Stage2
1.245390E-01
Normal-vs-Stage3
1.511390E-01
Normal-vs-Stage4
6.385400E-01
Stage1-vs-Stage2
1.545150E-01
Stage1-vs-Stage3
2.712400E-02
Stage1-vs-Stage4
8.341400E-01
Stage2-vs-Stage3
4.251800E-02
Stage2-vs-Stage4
3.899800E-01
Stage3-vs-Stage4
3.788100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.925190E-01
Normal-vs-AfricanAmerican
6.654400E-01
Normal-vs-Asian
6.553900E-02
Caucasian-vs-AfricanAmerican
3.916200E-01
Caucasian-vs-Asian
2.208000E-01
AfricanAmerican-vs-Asian
1.451170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.594220E-01
Normal-vs-Female
2.474000E-01
Male-vs-Female
3.971600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.151000E-01
Normal-vs-Age(41-60Yrs)
3.602200E-01
Normal-vs-Age(61-80Yrs)
1.575570E-01
Normal-vs-Age(81-100Yrs)
8.501800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.967800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.832200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.379200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.727700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.346400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.160000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.027900E-02
Normal-vs-Daily Drinker
1.786200E-02
Normal-vs-Weekly Drinker
1.524390E-01
Normal-vs-Occasional Drinker
3.606800E-01
Normal-vs-Social Drinker
5.067200E-01
Non Drinker-vs-Daily Drinker
4.586800E-01
Non Drinker-vs-Weekly Drinker
6.174800E-01
Non Drinker-vs-Occasional Drinker
3.010000E-02
Non Drinker-vs-Social Drinker
1.802980E-01
Daily Drinker-vs-Weekly Drinker
2.878800E-01
Daily Drinker-vs-Occasional Drinker
7.261600E-03
Daily Drinker-vs-Social Drinker
8.652500E-02
Weekly Drinker-vs-Occasional Drinker
2.034000E-01
Weekly Drinker-vs-Social Drinker
3.801200E-01
Occasional Drinker-vs-Social Drinker
9.371200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.573400E-01
Normal-vs-Grade 2
6.429600E-01
Normal-vs-Grade 3
6.512600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.607000E-01
Grade 1-vs-Grade 3
3.395400E-01
Grade 1-vs-Grade 4
2.573400E-01
Grade 2-vs-Grade 3
8.733800E-01
Grade 2-vs-Grade 4
6.429600E-01
Grade 3-vs-Grade 4
6.512600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.510000E-02
Normal-vs-NonDiabetic
1.322590E-01
Diabetic-vs-NonDiabetic
4.564600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.824300E-02
Normal-vs-NoPancreatitis
1.376210E-01
Pancreatitis-vs-NoPancreatitis
2.498800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.583000E-01
Normal-vs-N1
1.023050E-01
N0-vs-N1
1.480030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.055210E-01
Normal-vs-TP53-NonMutant
5.967800E-01
TP53-Mutant-vs-TP53-NonMutant
2.602000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
